Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Gabapentin
Hospital Authority, Hong Kong
Spinal Fusion
1 trial -
Galantamine
BRIGHT MINDS BIOSCIENCES INC.
Addiction
1 trial -
Gastrodin Injection
The First People's Hospital of Lianyungang
Sensorineural Hearing Loss
1 trial -
Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial -
Generic cetrorelix acetate
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
Glycerine Magnesium sulphate paste
Hospital Authority, Hong Kong
Infection
1 trial -
Goal2Quit + NRT Sampling
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
Goji berry
United Therapeutics Europe Ltd
Age-Related Macular Degeneration
1 trial -
Goserelin
The First People's Hospital of Lianyungang
Allogeneic Haematopoietic Stem Cell Transplantation
1 trial -
Goserelin 3.6 mg implant
Universal Integrated
Postpartum Depression
1 trial -
Green Tea Extract
United Therapeutics Europe Ltd
Dysbiosis
1 trial -
Group A (clinical guideline+machine learning)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Group S: sugammadex injection
Hospital Authority, Hong Kong
Head and Neck Surgery
1 trial -
Guideline-directed medical therapy
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
Guselkumab
BRIGHT MINDS BIOSCIENCES INC.
Psoriasis Vulgaris
1 trial -
HCV+PWID
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
HG204
The First People's Hospital of Lianyungang
MECP2 Duplication Syndrome
1 trial -
HIV self test
United Therapeutics Europe Ltd
HIV Infections
1 trial -
HLA-B*5801 test
BRIGHT MINDS BIOSCIENCES INC.
Stevens-Johnson Syndrome
1 trial -
HPV Self-Collection
Hospital Authority, Hong Kong
Cervical Cancers
1 trial -
Health education and conservative management of clinical routines
The First People's Hospital of Lianyungang
Recurrent Acute Pancreatitis
1 trial -
High Dose GGQL Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus, Type 2
1 trial -
High Fiber Diet Intervention
Universal Integrated
Dietary Fiber
1 trial -
High Hyaluronic Acid concentrations (0.5 mg/ml)
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources